Ian Michael Estepan

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian Michael Estepan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Chief Operating Officer Common Stock 193,300 $4,312,523 $22.31 16 Dec 2025 Direct
Sarepta Therapeutics, Inc. Chief Operating Officer Performance Restricted Stock Units 17,500 $2,056,425 $117.51 11 Feb 2025 Direct
Sarepta Therapeutics, Inc. Chief Operating Officer Performance Stock Units 6,250 $0 $100.13 05 Aug 2025 Direct
Sarepta Therapeutics, Inc. Chief Operating Officer Stock Options (right to buy) 16,644 10 Mar 2025 Direct
Sarepta Therapeutics, Inc. Chief Operating Officer Stock Option (right to buy) 0 29 Jan 2025 Direct

Insider Reports Filed by Ian Michael Estepan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRPT Sarepta Therapeutics, Inc. 16 Dec 2025 1 -$294,202 4 Chief Operating Officer 18 Dec 2025, 20:05
SRPT Sarepta Therapeutics, Inc. 03 Sep 2025 2 $0 4 Chief Operating Officer 05 Sep 2025, 21:30
SRPT Sarepta Therapeutics, Inc. 05 Aug 2025 1 $0 4 Chief Operating Officer 06 Aug 2025, 20:02
SRPT Sarepta Therapeutics, Inc. 07 Mar 2025 6 -$394,612 4 Chief Financial Officer 11 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 06 Mar 2025 4 -$1,003,712 4 Chief Financial Officer 10 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 04 Mar 2025 1 -$138,836 4 Chief Financial Officer 06 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 03 Mar 2025 1 -$57,800 4 Chief Financial Officer 04 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 11 Feb 2025 1 $0 4 Chief Financial Officer 13 Feb 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 29 Jan 2025 5 -$117,454 4 Chief Financial Officer 31 Jan 2025, 20:30
SRPT Sarepta Therapeutics, Inc. 27 Dec 2024 1 $0 4 Chief Financial Officer 30 Dec 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 30 Aug 2024 1 -$822,100 4 Chief Financial Officer 03 Sep 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 21 Jun 2024 5 -$408,801 4 Chief Financial Officer 25 Jun 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 07 Mar 2024 2 -$190,828 4 Chief Financial Officer 11 Mar 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 04 Mar 2024 1 -$174,069 4 Chief Financial Officer 06 Mar 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 01 Mar 2024 4 -$200,019 4 Chief Financial Officer 05 Mar 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 08 Mar 2023 1 -$113,973 4 Chief Financial Officer 10 Mar 2023, 19:00
SRPT Sarepta Therapeutics, Inc. 06 Mar 2023 3 -$215,378 4 Chief Financial Officer 08 Mar 2023, 19:00
SRPT Sarepta Therapeutics, Inc. 01 Mar 2023 1 -$55,781 4 Chief Financial Officer 03 Mar 2023, 19:00
SRPT Sarepta Therapeutics, Inc. 04 Mar 2022 4 -$135,179 4 Chief Financial Officer 08 Mar 2022, 19:02
SRPT Sarepta Therapeutics, Inc. 01 Mar 2022 1 -$28,219 4 Chief Financial Officer 01 Mar 2022, 19:02
SRPT Sarepta Therapeutics, Inc. 08 Sep 2021 1 -$127,065 4 Chief Financial Officer 09 Sep 2021, 20:00